Akebia Therapeutics AKBA
NASDAQ AKBA
$0.87 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Return on Assets [ROA] (2014 - 2026)

Updated

Akebia Therapeutics (AKBA) posted Return on Assets [ROA] of -8.33% for Q2 2026, up 2.80 percentage points from -11.13% a year earlier but down 2.78 percentage points from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Akebia Therapeutics' Return on Assets [ROA] came in at -1.79%, up 28.23 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +52.59 percentage points (FY2020 to FY2025).
  • In prior years, Akebia Therapeutics' Return on Assets [ROA] was -30.02% in FY2024 (-12.65 pp), -17.37% in FY2023 (+3.91 pp), -21.28% in FY2022 (+26.78 pp) and -48.07% in FY2021 (+6.32 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -48.39% in Q1 2022 to a high of -1.44% in Q4 2025 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last six quarters, with an average year-over-year change of +7.76 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2023, with a gain of 33.29 percentage points; the weakest was Q4 2024, with a drop of 10.66 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -5.55% (Q1 2026), -1.44% (Q4 2025) and -4.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Akebia Therapeutics 236.42 Mn -433.06 Mn 38.70 Mn -8.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.33%
Mar 31, 2026 -5.55%
Dec 31, 2025 -1.44%
Sep 30, 2025 -4.48%
Jun 30, 2025 -11.13%
Mar 31, 2025 -17.07%
Dec 31, 2024 -32.45%
Sep 30, 2024 -21.52%
Jun 30, 2024 -18.15%
Mar 31, 2024 -18.42%
Dec 31, 2023 -21.78%
Sep 30, 2023 -23.49%
Jun 30, 2023 -34.91%
Mar 31, 2023 -15.09%
Dec 31, 2022 -20.19%
Sep 30, 2022 -29.00%
Jun 30, 2022 -27.20%
Mar 31, 2022 -48.39%
Dec 31, 2021 -46.75%
Sep 30, 2021 -47.37%
API Access

Akebia Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEY